Hsbc Holdings PLC Sells 8,398 Shares of Cabot Corporation $CBT

Hsbc Holdings PLC trimmed its holdings in shares of Cabot Corporation (NYSE:CBTFree Report) by 72.9% in the first quarter, Holdings Channel.com reports. The firm owned 3,117 shares of the specialty chemicals company’s stock after selling 8,398 shares during the quarter. Hsbc Holdings PLC’s holdings in Cabot were worth $235,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Norges Bank bought a new stake in shares of Cabot during the fourth quarter worth $49,662,000. AQR Capital Management LLC lifted its position in Cabot by 123.0% in the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after acquiring an additional 478,702 shares in the last quarter. UBS Group AG boosted its stake in Cabot by 186.7% in the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after purchasing an additional 386,514 shares during the period. Pacer Advisors Inc. boosted its stake in Cabot by 3,165.7% in the 4th quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock worth $15,195,000 after purchasing an additional 222,232 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new position in Cabot during the 4th quarter worth about $8,785,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Trading Up 2.2%

Cabot stock opened at $90.00 on Tuesday. The company has a market cap of $4.65 billion, a price-to-earnings ratio of 17.01, a P/E/G ratio of 11.46 and a beta of 0.84. The firm has a 50-day moving average of $88.03 and a 200-day moving average of $79.56. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. Cabot Corporation has a one year low of $58.33 and a one year high of $94.53.

Cabot (NYSE:CBTGet Free Report) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The business had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. During the same quarter in the previous year, the business earned $1.90 earnings per share. Cabot’s quarterly revenue was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, equities analysts expect that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 annualized dividend and a dividend yield of 2.1%. Cabot’s payout ratio is 35.73%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on CBT shares. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Mizuho upped their price objective on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. UBS Group increased their price objective on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. JPMorgan Chase & Co. lifted their target price on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research report on Wednesday, May 13th. Finally, Wall Street Zen cut Cabot from a “buy” rating to a “hold” rating in a research note on Saturday. Two analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Cabot has a consensus rating of “Hold” and a consensus price target of $85.80.

Check Out Our Latest Analysis on CBT

Cabot Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Read More

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.